|
Palo Alto, CA, June 3, 2004 — Telik, Inc. (Nasdaq:
TELK) announced that company management will present an corporate
update at the Goldman Sachs 25th Annual Healthcare Conference on
Tuesday, June 8, 2004 at 4:00 p.m. Pacific time at the Ritz-Carlton
Hotel in Laguna Niguel, California.
Telik, Inc. of Palo Alto, CA is a biopharmaceutical company working
to discover, develop and commercialize small molecule drugs to treat
serious diseases including cancer. The company’s most advanced
drug development candidate is TELCYTA™. Telik’s product
candidates were discovered using its proprietary drug discovery
technology, TRAP, which enables the rapid and efficient discovery
of small molecule drug candidates. Additional information is available
at www.telik.com.
###
Contact:
Carol DeGuzman
Senior Director, Corporate Communications
Telik, Inc.
Tel 650-845-7728
Email cdeguzman@telik.com
Go to: 2004
Press Releases2003
Press ReleasesEvents
|
